Clinical utilities and biological characteristics of melanoma sentinel lymph nodes.

@article{Han2016ClinicalUA,
  title={Clinical utilities and biological characteristics of melanoma sentinel lymph nodes.},
  author={Dale Han and Daniel C. Thomas and Jonathan S. Zager and Barbara A. Pockaj and Richard L. White and Stanley P L Leong},
  journal={World journal of clinical oncology},
  year={2016},
  volume={7 2},
  pages={174-88}
}
An estimated 73870 people will be diagnosed with melanoma in the United States in 2015, resulting in 9940 deaths. The majority of patients with cutaneous melanomas are cured with wide local excision. However, current evidence supports the use of sentinel lymph node biopsy (SLNB) given the 15%-20% of patients who harbor regional node metastasis. More importantly, the presence or absence of nodal micrometastases has been found to be the most important prognostic factor in early-stage melanoma… CONTINUE READING

Similar Papers

Loading similar papers…